Literature DB >> 18521505

Deep vein thrombosis in patients with chronic kidney disease.

H Leon Daneschvar1, Ali Seddighzadeh, Gregory Piazza, Samuel Z Goldhaber.   

Abstract

Deep vein thrombosis (DVT) is a poorly understood complication of chronic kidney disease (CKD). The objective of our analysis was to profile DVT patients with and without CKD. We defined CKD as patients requiring dialysis or patients having nephrotic syndrome. We compared 268 patients with CKD (184 patients with dialysis-dependent renal disease and 84 with nephrotic syndrome) to 4,307 patients with preserved renal function from a prospective United States multicenter deep venous thrombosis (DVT) registry. Compared with non-CKD patients, CKD patients with DVT were younger (median age 62 vs. 69 years, p < 0.0001), more often African-American (p < 0.0001), and more often Hispanic (p = 0.0003). CKD patients underwent surgery more frequently in the three months prior to developing DVT (48.9% vs. 39.0%, p = 0.001) and more often had concomitant congestive heart failure (20.9% vs. 14.6%, p = 0.005). CKD patients suffered upper extremity DVT more frequently (30.0% vs. 10.8%, p < 0.0001). Patients with CKD presented less often with typical DVT symptoms of extremity discomfort (42.9% vs. 52.4%, p = 0.003) and difficulty ambulating (5.4% vs. 10.1%, p = 0.01). Prophylaxis rates prior to DVT were similarly low in CKD and non-CKD patients (44.2% vs. 38.0%, p = 0.06). Future studies of DVT in CKD patients should explore novel strategies for improving prophylaxis utilization and the detection of DVT in this special population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18521505     DOI: 10.1160/TH08-02-0107

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Impact of type of surgery on deep venous thrombi and pulmonary emboli: a look at twenty seven thousand hip fracture patients.

Authors:  Vasanth Sathiyakumar; Sarah E Greenberg; Alex A Jahangir; Hassan H Mir; William T Obremskey; Manish K Sethi
Journal:  Int Orthop       Date:  2015-07-09       Impact factor: 3.075

Review 2.  [Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].

Authors:  G Schlieper; V Schwenger; A Remppis; T Keller; R Dechend; S Massberg; S Baldus; T Weinreich; G Hetzel; J Floege; F Mahfoud; D Fliser
Journal:  Internist (Berl)       Date:  2017-05       Impact factor: 0.743

3.  The Prophylaxis of Venous Thromboembolism.

Authors:  Albrecht Encke; Sylvia Haas; Ina Kopp
Journal:  Dtsch Arztebl Int       Date:  2016-08-08       Impact factor: 5.594

4.  Venous thromboembolism in patients with reduced estimated GFR: a population-based perspective.

Authors:  Amisha M Parikh; Frederick A Spencer; Darleen Lessard; Catherine Emery; Ana Baylin; Crystal Linkletter; Robert J Goldberg
Journal:  Am J Kidney Dis       Date:  2011-08-27       Impact factor: 8.860

5.  Improved utilisation of venous thromboembolism prophylaxis in renal-impaired patients following a clinical pharmacist intervention.

Authors:  Naemeh Nikvarz; Zahra Seyedi
Journal:  Eur J Hosp Pharm       Date:  2019-12-11

6.  Pulmonary embolism in patients with CKD and ESRD.

Authors:  Gagan Kumar; Ankit Sakhuja; Amit Taneja; Tilottama Majumdar; Jayshil Patel; Jeff Whittle; Rahul Nanchal
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-26       Impact factor: 8.237

7.  Venous thromboembolism in patients with diabetes mellitus.

Authors:  Gregory Piazza; Samuel Z Goldhaber; Aimee Kroll; Robert J Goldberg; Catherine Emery; Frederick A Spencer
Journal:  Am J Med       Date:  2012-05-03       Impact factor: 4.965

8.  A Retrospective cohort study on the risk factors of deep vein thrombosis (DVT) for patients with traumatic fracture at Honghui Hospital.

Authors:  Wenjuan Zhang; Ying Huai; Wei Wang; Kaiyue Xue; Lei Chen; Chu Chen; Airong Qian
Journal:  BMJ Open       Date:  2019-03-03       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.